Monday, March 07, 2016 10:01:28 PM
2015 year-end debt: $100.1 million. A decrease of $12.0 million from year-end 2014.
2015 year-end net debt: $93.2 million. A decrease of $13.8 million from year-end 2014.
2015 revenue: $71.1 million. A decrease of 3.7% from 2014. Revenue loss was 6.5% in the 2013 to 2014 period. Revenue loss is slowing.
2015 year-end leverage: 3.38:1. A decrease from 2014 year-end leverage of 3.90:1.
2015 EPS: $2.26/share. An increase from 2014 year-end EPS of $1.59/share.
2015 Operating Income: $19.3 million. An increase of $2.4 million from 2014.
Trading at 3.7x trailing twelve month EBITDA.
New 5 year credit line.
They don't get any cheaper than this folks.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM